Noxarem (Melatonin)

Melatonin, the active ingredient in Noxarem, is a hormone‑based sleep aid presented as an oral formulation for systemic use. It helps regulate the sleep‑wake cycle and is used in adults who experience difficulty falling asleep or adjusting to time‑zone changes.

GNH USA supplies Noxarem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noxarem acts on the body’s circadian rhythm to support normal sleep patterns. - Insomnia: helps reduce the time needed to fall asleep in adults. - Jet lag: assists in resetting the internal clock after rapid east‑west travel. - Shift‑work disorder: promotes sleep onset when work schedules disrupt normal night‑time rest.

Melatonin is generally well tolerated, but some users report mild reactions.

Common Side Effects: - Headache: mild, transient headache. - Drowsiness: excessive sleepiness during daytime. - Gastrointestinal discomfort: nausea or mild stomach upset. - Vivid dreams: unusually vivid or memorable dreams. - Dizziness: light‑headed feeling. - Mood changes: mild irritability or emotional lability.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hormonal effects: menstrual irregularities or altered libido. - Severe dizziness or fainting. - Persistent depression or mood worsening. - Rapid heart rate or palpitations. - Severe gastrointestinal upset with vomiting.

When using Noxarem, consider the following safety measures: - Age limitation: not recommended for children without medical supervision. - Pregnancy: discuss use with a healthcare professional before taking. - Breastfeeding: consult a physician to weigh potential risks and benefits. - Concomitant CNS depressants: monitor for additive drowsiness. - Underlying sleep disorders: ensure proper diagnosis before self‑medication. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Melatonin may interact with several medication classes.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: potential alteration of immune response. - Central nervous system depressants: risk of excessive sedation.

Moderate Interactions (Monitor Closely): - Hormonal contraceptives: possible reduction in efficacy. - Antidiabetic drugs: may affect blood‑glucose monitoring. - Antihistamines: could enhance drowsiness.